Hanmi Science Co., Ltd. (KRX:008930)
28,100
+150 (0.54%)
Apr 18, 2025, 3:30 PM KST
Hanmi Science Revenue
In the year 2024, Hanmi Science had annual revenue of 1.28T KRW with 2.85% growth. Hanmi Science had revenue of 331.71B in the quarter ending December 31, 2024, a decrease of -0.07%.
Revenue
1,283.43B
Revenue Growth
+2.85%
P/S Ratio
1.48
Revenue / Employee
2.89B
Employees
444
Market Cap
1,902.76B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,283.43B | 35.53B | 2.85% |
Dec 31, 2023 | 1,247.91B | 201.85B | 19.30% |
Dec 31, 2022 | 1,046.05B | 95.89B | 10.09% |
Dec 31, 2021 | 950.16B | 92.78B | 10.82% |
Dec 31, 2020 | 857.38B | 40.76B | 4.99% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 68.13B |
LigaChem Biosciences | 125.90B |
PharmaResearch | 350.12B |